Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01857128
Other study ID # 382094-2
Secondary ID
Status Recruiting
Phase Phase 4
First received May 7, 2013
Last updated May 17, 2013
Start date March 2013

Study information

Verified date May 2013
Source Walter Reed National Military Medical Center
Contact Michael P McNally, M.D.
Phone 301-295-4442
Is FDA regulated No
Health authority United States: Food and Drug AdministrationUnited States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of the study is to learn about the best way to treat pilonidal cyst wounds and learn which type of bandage (or dressing) can help the wound heal faster after having surgery.


Description:

This pilot study is a prospective randomized open-label study examining the efficacy of Drawtex® Hydroconductive wound dressing and negative pressure wound therapy(NPWT) in pilonidal cystectomy wound healing by secondary intention.

Pilonidal disease has a significant impact on the active duty demographic and the treatments for this disease result in a substantial cost to the military in both duty days lost and for the medical care provided. This study examines Negative Pressure Wound Therapy (NPWT) and the Drawtex® Hydroconductive Dressing for the treatment of surgical wounds resulting from limited excision of pilonidal disease. This clinical trial is a prospective, randomized open label examination of two standard wound therapy modalities with the goal of determining which treatment promotes the most rapid wound healing by secondary intention. Secondary goals include determining which treatment is most cost effective and is most acceptable to patients.

Active duty, retired, and dependent adults (age 18-60 years) who are scheduled to undergo limited surgical cyst excision will be recruited from patients who are referred to the General Surgery Department at Walter Reed National Military Medical Center (WRNMMC). Health care providers in the General Surgery Department will be informed about the study and requested to refer appropriate patients to the study Investigators for evaluation and potential inclusion in the study. The informed consent process will occur at WRNMMC, General Surgery Clinic during the pre-operative clinic visit(s). If the patient consents to screening for inclusion in the study, then they will be assigned a subject number and randomly assigned to a study arm, either NPWT or Drawtex®, preoperatively. The subject will then undergo a limited excision of the pilonidal cyst. If the resulting wound post-surgery meets enrollment criteria, then the subject will be enrolled in the study. At this point, the randomization arm will be revealed either NPWT or Drawtex® dressing. Wound care will be done at the wound care clinic two times a week (biweekly) for approximately 4 weeks or until there is 75% epithelialization, and then on a weekly and then on a monthly basis until 100% epithelialization of the wound or 270 days of follow up are reached. Wound healing progress will be evaluated objectively using a digital planimetry analysis system and blinded evaluators. Secondary objectives include adverse events, bacterial load, expression of inflammatory markers, cost to military and patient satisfaction assessments,


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

1. Healthy adult male or non-lactating female age 18 to 60 years inclusive.

2. Diagnosis of pilonidal disease with cyst requiring surgery, with undermining to remove the cyst and requiring limited excision with healing by secondary intension.

3. Presence of chronic symptomatic pilonidal disease defined as at least one pilonidal sinus and a history of at least two acute pilonidal abscesses or persistent symptoms altering patient's quality of life.

4. Military active duty members need a supervisor signed memorandum to participate (Active Duty Supervisor's Approval Memo).

5. Understands the purpose and risks of study by scoring 80% or higher on knowledge assessment test.

6. Available and willing to participate for the duration of the study (approximately 30-270 days maximum depending on time to wound healing).

7. Available and willing to provide written informed consent.

8. Able and willing to follow instructions as per protocol.

9. Available for all visits as per protocol. Post Surgery Study Enrollment Criteria

10. Post-surgical wound measurement (length x width x depth):

(cm x 1.5 cm x 1.5 cm)greater than or equal to 3 cm in length, greater than or equal to 1.5 cm in width, and greater than or equal to1.5 cm in depth.

Rationale: satisfies the minimum size wound that NPWT may be employed.

Exclusion Criteria:

1. Does not meet all inclusion criteria.

2. Pregnant (by history or as ascertained by pregnancy test) or lactating female Rationale: immune modulation and potential for altered healing trajectory as well as operative risk to fetus for elective procedure.

3. Known HIV infection.

4. Known immunodeficiency or currently receiving immunosuppressive therapy (inhaled and topical steroids are allowed).

5. Autoimmune disease (clinical, preexisting anti-dsDNA antibodies 30 IU, or positive ANA ELISA with a titer greater than 1:80 on pre-operative screening) Exclusionary medical histories will include the following diagnoses: systemic lupus erythematosus, rheumatoid arthritis, mixed connective tissue disease, progressive systemic sclerosis, Sjogren's syndrome, polymyositis/ dermatomyositis, and vasculitis Rationale: potential for altered wound healing.

6. Acute or chronic, clinically significant cardiac, pulmonary, hepatic, or renal abnormality, as determined by physical examination or basic laboratory screening performed at pre-operative evaluation.

7. Known documented history of diabetes mellitus.

8. Non-ambulatory or limited mobility. Rationale: non ambulatory patients may have altered wound healing in the sacral area due to constant pressure from positioning.

9. History of current tobacco use: defined as cigarette smoking greater than or equal to one half pack (10 cigarettes) per day:

Rationale: confounding factor prolonging wound healing.

10. Complex pilonidal disease determined by the surgeon to require a procedure other than the study procedure for appropriate treatment of the disease.

11. Acute pilonidal abscess or infection within 6 weeks of planned operative date.

12. Concerns for arterial bleeding or cancer in the wound bed or in the vicinity of the dressing.

13. Any other significant finding which, in the opinion of the investigator, would increase the subject's risk of having an adverse outcome from participating in this protocol.

14. Lack of or unwillingness to provide/sign informed consent. Post Surgery Exclusion Study Criteria

15. Post-surgical wound measurement restrictions (enth x width x depth):

(0 cm x 10 cm x 6 cm)greater than or equal to 10 cm in length, greater than or equal to 10 cm in width OR greater than or equal to 6 cm in depth. If bone is visible or exposed, the subject must be excluded.

Rationale: large wounds are deemed complex and wounds with exposed or visible bone require antibiotic therapy.

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Drawtex dressing

Negative Pressure Wound Therapy


Locations

Country Name City State
United States Walter Reed National Military Medical Center -Dept of General Surgery Bethesda Maryland

Sponsors (2)

Lead Sponsor Collaborator
Walter Reed National Military Medical Center United States Department of Defense

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to wound healing Time (days) to 100% epithelialization of the wound bed will be evaluated using digitized planimetry in a random manner by two independent evaluators blinded to the study treatment. Up to 270 days or 9 months No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03276065 - Effectiveness of Laser Hair Removal in Pilonidal Disease N/A
Completed NCT06206330 - Effect of Platelet Rich Plasma (PRP) on Healing Time in Patients Following Pilonidal Sinus Surgery N/A
Recruiting NCT03483480 - Non-Powered Negative Pressure Wound Therapy vs Open Technique for Pilonidal Disease N/A
Not yet recruiting NCT06140199 - Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone) N/A
Recruiting NCT06391307 - The Role of Mesenchymal Stem Cell and Exosome in Treating Pilonidal Sinus Disease in Children N/A
Not yet recruiting NCT06286397 - Topical Anti-Androgens in Pilonidal Sinus Disease Phase 2
Not yet recruiting NCT03415347 - De-roofing and Curettage vs WLE for Pilonidal Abscess N/A
Terminated NCT04041037 - The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series
Not yet recruiting NCT06406621 - Laser Hair Depilation Darker Skin Pilonidal Disease N/A
Completed NCT05569135 - Debridement and Laser Ablation Versus Debridement Alone in Pilonidal Disease
Completed NCT04697082 - Application of Platelet-rich Plasma in Pilonidal Sinus Disease N/A
Terminated NCT03534700 - Excision and Reconstruction of the Natal Cleft With a Parasacral Perforator Flap Versus Open Excision With Secondary Healing, in the Management of Sacrococcygeal Pilonidal Disease. N/A
Recruiting NCT05439291 - Comparing Operative vs Non Operative Treatment for Pilonidal Disease N/A
Recruiting NCT05830734 - Injection of Freshly Collected Autologous Adipose Tissue Additional to Bascom's Cleft Lift Surgery N/A
Terminated NCT03458663 - Randomized Trial Comparing Prevena and ActiV.A.C. System to Convetional Care After Bascom's Cleft Lift Surgery N/A
Completed NCT05404243 - Clinical Trial to Test the Phenolization in Sacrococcygeal Pilonidal Disease Phase 4
Active, not recruiting NCT03772873 - MIPE for Pilonidal Disease
Recruiting NCT02330159 - Feasibility of a Novel Technique for Pilonidal Wound Healing N/A
Completed NCT02186964 - Comparison of Tension Free Primary Closure, Karydaks and Limberg Flap Methods N/A
Completed NCT01268969 - Comparison Between Two Different Technique in Treatment of Chronic Pilonidal Disease N/A